Market Outlook


  • Thursday's Market Roadmap  Thursday, 28 Feb 2013 | 9:00 AM ET

    The "Squawk on the Street" news team reports on today's top businesses headlines, including the Dow and S&P nearing all-time highs; JC Penney's larger-than-expected fourth quarter loss; and two big banks downgrading Groupon.

  • Jobless Claims Down 22K & Q4 GDP (Revised) Up 0.1%  Thursday, 28 Feb 2013 | 8:30 AM ET

    CNBC's Rick Santelli provides the read on unemployment and fourth quarter GDP numbers. And, CNBC's Steve Liesman and Drew Matus, UBS economist, discuss what it signals about the economic recovery and markets.

  • Trader's Buzz Before the Bell  Thursday, 28 Feb 2013 | 8:18 AM ET

    CNBC's Becky Quick provides an update on Kohl's and JC Penney's Q4 earnings. And, Jim Iuorio, TJM Institutional Services, takes a look at what traders are watching ahead of the market's open.

  • The ECB Doesn't Have a 'Big Toolbox': Expert  Thursday, 28 Feb 2013 | 7:48 AM ET

    Michael Novogratz, Fortress Investment Group; and Constance Hunter, International Solutions Network Consulting, discuss ways the European Central Bank will be able to turnaround Europe's current economic crisis.

  • Euro Split? Currency War? Not, Says ECB's Top Wonk Thursday, 28 Feb 2013 | 7:39 AM ET
    European Central Bank (ECB) headquarters in Frankfurt, Germany.

    There has been "clear improvement" in the economic situation in Europe over the past year, European Central Bank policymaker Ewald Nowotny told CNBC.

  • Bernanke vs. the Markets  Thursday, 28 Feb 2013 | 7:06 AM ET

    CNBC's Steve Liesman discusses whether comments from Ben Bernanke on the Fed's continued support of its stimulus policy helped spark the market's rally. And, Michael Novogratz, Fortress Investment Group; and Constance Hunter, International Solutions Network Consulting, weigh in on the sequester issue and whether Bernanke is making progress.

  • Thomas Watjen, President & CEO of Unum, discusses the "high level" issues facing many consumers living paycheck to paycheck, and the difficulty getting adequate insurance coverage.

  • Does the Sequester Matter?  Thursday, 28 Feb 2013 | 6:35 AM ET

    CNBC's John Harwood takes a look at the calendar and explains why the markets may or may not care about the automatic spending cuts set to kick in by the March 1st deadline.

  • Tracking the Market's Bright Spots  Thursday, 28 Feb 2013 | 6:20 AM ET

    Christian Thwaites, Sentinel Investments; and Mark Vitner, Wells Fargo Securities, provide perspective on the markets and economy, despite the looming sequester and political unrest in Italy.

  • Pre-Market Report: What You Need to Know  Thursday, 28 Feb 2013 | 6:00 AM ET

    CNBC's Kelly Evans tells you what the markets will be watching as we approach the start of trading in the U.S. (1:19)

  • More Volatility Ahead  Thursday, 28 Feb 2013 | 12:00 AM ET

    Stuart Oakley, Managing Director, Asian Currency Trading at Nomura, and John Woods, Chief Investment Strategist at Citi Private Bank says expect more market consolidation before a pick up.

  • Sequester to Only Last 30 Days  Wednesday, 27 Feb 2013 | 7:45 PM ET

    The latest on the sequester, with Richard Socarides strategist, and Dick Morris, former Clinton advisor.

  • CPAC Takes a Pass on Christie  Wednesday, 27 Feb 2013 | 7:41 PM ET

    Have conservatives dissed Chris Christie? Star Parker, Cure founder & president, and Al Cardenas, American Conservative, discuss.

  • Flowers Foods Pays $360M for Hostess Wonder Bread Unit  Wednesday, 27 Feb 2013 | 7:30 PM ET

    CNBC's Bertha Coombs has the latest business headlines.

  • Dow Closes at 5-Year High  Wednesday, 27 Feb 2013 | 7:16 PM ET

    The Dow extends February gains, with Abigail Doolittle, CNBC contributor.

  • White House Scare Tactics  Wednesday, 27 Feb 2013 | 7:00 PM ET

    Dick Morris, former Clinton advisor; Richrd Socarides, Democratic strategist; and Jim Demint, Heritage.org, discuss the threat of the anti-growth tax hike.

  • No Huddle Offense: Lacking Logic?  Wednesday, 27 Feb 2013 | 6:58 PM ET

    Mad Money host Jim Cramer explains how not to get drawn into poor investing ideas.

  • Alkermes CEO Talks Biotech  Wednesday, 27 Feb 2013 | 6:45 PM ET

    Alkermes is a pharmaceutical company with a portfolio of over 20 commercial drug products. Richard F. Pops, Alkermes CEO, weighs in.

  • Linn Energy CEO on Taking Risks  Wednesday, 27 Feb 2013 | 6:25 PM ET

    Mark E. Ellis, Linn Energy chairman, president & CEO, says his company's hedges allow them to take very little commodity price risk.

  • Ariad Pharmaceuticals CEO Talks Earnings  Wednesday, 27 Feb 2013 | 6:15 PM ET

    Aria uses structure-based drug design to identify molecules able to overcome resistance in therapy. Dr. Harvey Berger, Aria Pharmaceuticals chairman & CEO, offers insight on earnings.